Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Prenatal Androgen and Skills

30 mai 2026 mis à jour par: Rabia ZORLULAR, Nigde Omer Halisdemir University

Prenatal Androgen and Fine Motor Skills and Tactile Discrimination

Due to the difficulties and risks of directly measuring prenatal hormone levels, biomarkers that indirectly reflect this exposure are used in research. In this context, the ratio of second to fourth finger length (2D:4D) is widely preferred because it is an easily applicable and non-invasive measurement. Evidence shows that 2D:4D stabilizes from the second trimester of pregnancy onward and exhibits strong sex differences across populations. The 2D:4D ratio is generally lower in men than in women. 2D is more strongly influenced by prenatal estrogen, while 4D is more strongly influenced by prenatal testosterone; this occurs during the first trimester of intrauterine fetal development. To our knowledge, studies examining the relationship between the 2D:4D ratio, an indirect indicator of prenatal androgen exposure, and dexterity and tactile discrimination are limited. Accordingly, the planned study aims to evaluate the relationship between the 2D:4D ratio and fine motor skills and tactile discrimination in healthy young adults.

Aperçu de l'étude

Statut

Inscription sur invitation

Les conditions

Description détaillée

Sex hormones experienced during prenatal exposure play a significant role in shaping certain lifelong characteristics by influencing both the physical and neurological development of individuals. The effects of these hormones, particularly on the developing nervous system, contribute to the emergence of behavioral and functional differences. Hand preference and certain behavioral traits in humans have been shown to be related to prenatal hormonal exposure. However, the development of these traits is not limited to hormonal influences alone, but is shaped by the interaction of genetic, environmental, and sociocultural factors. Due to the difficulties and risks of directly measuring prenatal hormone levels, biomarkers that indirectly reflect this exposure are used in research. In this context, the ratio of second to fourth finger length (2D:4D) is widely preferred because it is an easily applicable and non-invasive measurement. The 2D:4D ratio is generally lower in men than in women. 2D is more strongly influenced by prenatal estrogen, while 4D is more strongly influenced by prenatal testosterone; this occurs during the first trimester of intrauterine fetal development. However, whether the 2D:4D ratio is a reliable indicator of prenatal hormonal exposure is still a controversial issue in the literature. Therefore, examining the relationship between the 2D:4D ratio and various biological and functional characteristics remains important. To our knowledge, studies examining the relationship between the 2D:4D ratio, an indirect indicator of prenatal androgen exposure, and dexterity and tactile discrimination are limited. Accordingly, the planned study aims to evaluate the relationship between the 2D:4D ratio and fine motor skills and tactile discrimination in healthy young adults. It is hypothesized that prenatal hormonal exposure may indirectly shape finger morphology and receptor distribution by affecting skin and nervous system development, which may be a determining factor in tactile sensitivity and dexterity.

Type d'étude

Observationnel

Inscription (Estimé)

94

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Merkez
      • Niğde, Merkez, Turquie (Türkiye)
        • Nigde Omer Halisdemir University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

- Healthy individuals aged 18-40

La description

Inclusion Criteria:

  • Healthy individuals aged 18-40
  • Having sufficient visual and auditory function to understand and administer the test,
  • Voluntary agreement to participate in the study and providing informed consent.

Exclusion Criteria:

  • Individuals with any musculoskeletal pathology,
  • History of upper extremity trauma,
  • Individuals diagnosed with metabolic, neurological, or genetic diseases,
  • Individuals with a history of hand surgery within the last 6 months,
  • Pregnancy or breastfeeding.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Healthy adults
Young and healthy adults aged 18-40
The second (2D) and fourth (4D) finger lengths of the participants will be measured separately in both hands by a physiotherapist with over thirteen years of clinical experience.
Hand dexterity will be assessed using the Purdue Pegboard Test. The test will be administered according to standard procedure with participants seated at a table. Participants will be asked to place the pegs into the corresponding holes as quickly and accurately as possible within a specified time (30 seconds).
To perform the 2-point discrimination tests, the Baseline® two-point discriminator will be used. Measurements will be applied to the distal phalangeal pulp of the index finger on both hands while participants are seated in a comfortable position with their eyes closed.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
2-point discrimination test
Délai: 12 months
To perform 2-point discrimination tests, the Baseline® two-point discriminator will be used. Measurements will be applied to the distal phalangeal pulp of the index finger on both hands while participants are seated in a comfortable position with their eyes closed. The test will begin at a distance of 8 mm, allowing participants to perceive the stimulus as two points, and then the distance will be gradually reduced. After 5 mm, measurements will continue at 1 mm intervals. In each application, both contact points will be applied to the skin simultaneously and with equal pressure, and participants will be asked to indicate whether the perceived stimulus is a single point or two points.
12 months
Digit Ratio
Délai: 12 months

Measurements will be taken after participants' hands are placed on a flat surface with palms facing upwards. Finger length is defined as the distance from the midpoint of the proximal crease line where the finger joins the palm to the distal point of the fingertip.

Measurements will be performed using a digital caliper with 0.01 mm accuracy, two separate measurements will be taken for each finger, and the average value will be recorded. Based on the obtained measurements, the 2D:4D finger ratio will be calculated by dividing the 2D length by the 4D length in both hands .

12 months
Fine motor skills
Délai: 12 months
The test will be administered according to standard procedure while participants are seated at a table. Participants will be asked to place the pegs into the corresponding holes as quickly and accurately as possible within the specified time (30 seconds). In the dominant and non-dominant hand tests, participants will be asked to place pegs with one hand for 30 seconds, while in the both-hand test, the simultaneous use of both hands will be evaluated. The number of correctly placed pegs for each subtest will be recorded, and higher scores will be considered as better fine motor skill performance.
12 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Rabia ZORLULAR, Nigde Omer Halisdemir University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 juillet 2026

Achèvement primaire (Estimé)

1 juillet 2027

Achèvement de l'étude (Estimé)

1 juillet 2027

Dates d'inscription aux études

Première soumission

30 mai 2026

Première soumission répondant aux critères de contrôle qualité

30 mai 2026

Première publication (Réel)

4 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

4 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

30 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner